Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00646958 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections
A Phase 2 study, sponsored by Melinta Therapeutics.
- Completed
- Registry status
- Phase 2
- Development phase
- 150
- Enrollment target
NCT00646958 is a Phase 2 study that has completed, run by Melinta Therapeutics. The registered enrollment target is 150 participants.
The verdict
NCT00646958, a Phase 2 study, has completed, sponsored by Melinta Therapeutics.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 150 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the efficacy, safety and tolerability of RX-1741, an oxazolidinone, versus linezolid, another oxazolidinone, in the treatment of uncomplicated skin and skin structure infections
Interventions
- DRUG Linezolid
- DRUG Radezolid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00646958
The ClinicalTrials.gov registry entry for NCT00646958 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Melinta Therapeutics, which has 31 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Linezolid is the first listed.
NCT00646958 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00646958 about?
NCT00646958 is a clinical study titled "Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections". The purpose of this study is to assess the efficacy, safety and tolerability of RX-1741, an oxazolidinone, versus linezolid, another oxazolidinone, in the treatment of uncomplicated skin and skin structure infections
What is the current status of trial NCT00646958?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 150 participants. The study started on 2007-12. Estimated completion is 2008-04.
What interventions are being tested in trial NCT00646958?
The interventions under investigation include: Linezolid (DRUG), Radezolid (DRUG).
Who is sponsoring clinical trial NCT00646958?
This trial is sponsored by Melinta Therapeutics, which has 31 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.